Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers
At two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of
Read MoreAt two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of
Read MoreA planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says it
Read MoreThe prohibition halts support for projects both inside and outside the N.I.H. President Biden had restored funding after an earlier
Read MoreResearchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it
Read MoreLeaders of the D.S.M., the world’s most influential psychiatric manual, have been split for more than five years over whether
Read MoreTwo regulatory rollbacks, along with a new A.I. experiment in Medicare, raise some worrisome questions.
Read MoreThe review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of neurodevelopmental
Read MoreThe long-awaited plan would leave much to Congress and calls for payments to health savings accounts rather than insurance subsidies,
Read MoreFederal officials working on the new dietary guidelines had considered limiting men to one drink daily. The final advice was
Read MoreThe Trump administration has signed $11 billion in agreements with African nations, in deals tied to foreign policy goals.
Read More